Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Moore Kuehn Encourages CBMG, CLCT, TNAV, and ARA Investors to Contact Law Firm
Moore KuehnDecember 29, 2020 GMT
NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may ultimately seek increased consideration, additional disclosures, or other relief and benefits on behalf of the shareholders of these companies: Cellular Biomedicine Group, Inc. (NASDAQ: CBMG)
A proxy was recently filed with the SEC regarding the acquisition of Cellular Biomedicine by a consortium led by the company’s CEO Bizuo Liu. Under the proposed transaction, shareholders of Cellular Biomedicine will receive $19.75 for every share owned. The investigation concerns whether Cellular Biomedicine
Contra Guys: Our picks really panned out in a turbulent year
theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.
MERGER ALERT - FIII, CLCT, and NPA: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies
albuquerqueexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albuquerqueexpress.com Daily Mail and Mail on Sunday newspapers.
WeissLaw LLP Reminds CLCT, JWS, TGC, and TNAV Shareholders About Its Ongoing Investigations
News provided by
Share this article
If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of
Collectors Universe, Inc.
(NASDAQ: CLCT) in connection with the proposed acquisition of the company by an investor group led by entrepreneur and sports card collector Nat Turner, D1 Capital Partners L.P., and Cohen Private Ventures, LLC. Under the terms of the agreement, the company s shareholders will receive $75.25 in cash for each share of CLCT common stock that they hold. If you own CLCT shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our
Cellular Biomedicine Group, Inc. (NASDAQ: CBMG)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CBMG to members of CBMG management.
If you are a CBMG investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780.
Cleveland BioLabs, Inc. (NASDAQ: CBLI)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger of CBLI with Cytocom.
If you are a CBLI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].